No Data
Eagle Eye Technology-B (02251): The China Securities Regulatory Commission has approved full circulation of Listed in Hong Kong shares.
Eagle Eye Technology-B (02251) announced that the company recently received a notice from the China Securities Regulatory Commission regarding Peking Eagle Eye Technology Development...
AIRDOC-B: 2024 ANNUAL REPORT
Eagle Eye Technology-B (02251) announced its annual performance, achieving revenue of 0.156 billion yuan, with the usage of myopia prevention AI products reaching 4.025 million times, a year-on-year increase of 352.1%.
Eagle Eye Technology-B (02251) announced the annual performance for the year ending December 31, 2024, during which the group achieved...
AIRDOC-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024
AIRDOC-B: DATE OF BOARD MEETING
GF SEC: The recovery of Medical IT Orders in February, pay attention to the subsequent implementation of AI Orders.
With the continuous deepening of AI technology applications and the increasingly sound Medical data security and compliance framework, it is expected that the demand for Medical IT will steadily rise in the next 3-5 years.
